Shedding light on a Fat-Related protein after stomach surgery
NCT ID NCT07335549
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 40 people with severe obesity who had laparoscopic sleeve gastrectomy, a type of weight-loss surgery. Researchers measured levels of a protein called isthmin in the blood before surgery and three months after. The goal was to see if isthmin, which is linked to metabolism and appetite, changes after significant weight loss. The study is purely observational and does not test any drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could clarify how isthmin levels change after weight-loss surgery, pointing toward new ways to understand or treat obesity-related metabolic issues.
- What could go wrong
- This is a small, completed observational study with only 40 participants. It measures a biomarker (isthmin) and does not test a treatment, so it cannot directly lead to a therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
40 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
BMI \> 40 kg/m2 without comorbidity who are planned for Laparoscopic Sleeve Gastrectomy
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being over 18 years of age * Being diagnosed with severe obesity * Patients who do not wish to participate in the study Exclusion Criteria: * Patients under 18 years of age * Overweight patients with a Body Mass Index \<40 kg/m2 and no comorbidities * Patients with rheumatological diseases (rheumatoid arthritis, SLE, etc.) * Patients with chronic kidney and liver failure * Patients diagnosed with Diabetes Mellitus * Patients with malignancy * Patients who do not wish to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adipokines are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Elazig Fethi Sekin City Hospital
Elâzığ, 23100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cooking classes curb dangerous pregnancy weight gain?
- Do teens who know more about obesity weigh less?
- Can a starch powder trick the gut into curbing teen appetite?
- Can a Choose-Your-Own-Adventure comic help kids eat better and move more?
- Can a Weight-Loss drug and an IUD treat early uterine cancer without surgery?
- Can a Three-Part program help older adults lose fat and keep muscle?